195 related articles for article (PubMed ID: 27446959)
21. Lack of association of MTHFR gene polymorphisms with the risk of osteonecrosis of the femoral head in a Korean population.
Kim TH; Hong JM; Kim HJ; Park EK; Kim SY
Mol Cells; 2010 Apr; 29(4):343-8. PubMed ID: 20229089
[TBL] [Abstract][Full Text] [Related]
22. Association of SREBP2 gene polymorphisms with the risk of osteonecrosis of the femoral head relates to gene expression and lipid metabolism disorders.
Song Y; Du Z; Chen B; Ren M; Yang Q; Sui Y; Wang Q; Wang A; Zhao H; Qin Y; Zhang G
Mol Med Rep; 2017 Nov; 16(5):7145-7153. PubMed ID: 28901487
[TBL] [Abstract][Full Text] [Related]
23. Preliminary screening of differentially expressed circulating microRNAs in patients with steroid‑induced osteonecrosis of the femoral head.
Wang X; Qian W; Wu Z; Bian Y; Weng X
Mol Med Rep; 2014 Dec; 10(6):3118-24. PubMed ID: 25323050
[TBL] [Abstract][Full Text] [Related]
24. A Network Pharmacology and Molecular Docking Strategy to Explore Potential Targets and Mechanisms Underlying the Effect of Curcumin on Osteonecrosis of the Femoral Head in Systemic Lupus Erythematosus.
Kang P; Wu Z; Zhong Y; Wang Z; Zhou C; Huo S; Guo H; Li S; Xu K; Liu L; Chen S; Tang H; Wang H
Biomed Res Int; 2021; 2021():5538643. PubMed ID: 34557547
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in the coagulation factor V gene and risk of femoral head osteonecrosis.
Kim TH; Baek SH; Lim JO; Lee SH; Kim SY
Mol Med Rep; 2015 Sep; 12(3):4434-4440. PubMed ID: 26130054
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of incidence and clinical characteristics of osteonecrosis of femoral head in patients with systemic lupus erythematosus treated with glucocorticoid: A descriptive study based on a prospective cohort].
Xu Y; Chen S; Cai Q; Zhang C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 May; 37(5):605-614. PubMed ID: 37190840
[TBL] [Abstract][Full Text] [Related]
27. ABCB1 polymorphisms associated with osteonecrosis of the femeral head.
Zhang Z; Li Y; Liu H; Shi J; Li X; Jiang W
Int J Clin Exp Pathol; 2015; 8(11):15240-4. PubMed ID: 26823873
[TBL] [Abstract][Full Text] [Related]
28. The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus.
Lan Y; Luo B; Wang JL; Jiang YW; Wei YS
Gene; 2014 Mar; 538(1):94-8. PubMed ID: 24434811
[TBL] [Abstract][Full Text] [Related]
29. An intron SNP rs2069837 in IL-6 is associated with osteonecrosis of the femoral head development.
Wang R; Li R; Liu R
BMC Med Genomics; 2022 Jan; 15(1):5. PubMed ID: 34986839
[TBL] [Abstract][Full Text] [Related]
30. Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population.
Zhang Y; Kong X; Wang R; Li S; Niu Y; Zhu L; Chen W; Lin N
Mol Biol Rep; 2014 May; 41(5):3135-46. PubMed ID: 24469730
[TBL] [Abstract][Full Text] [Related]
31. Association of a polymorphism in the intron 7 of the SREBF1 gene with osteonecrosis of the femoral head in Koreans.
Lee HJ; Choi SJ; Hong JM; Lee WK; Baek JI; Kim SY; Park EK; Kim SY; Kim TH; Kim UK
Ann Hum Genet; 2009 Jan; 73(1):34-41. PubMed ID: 19040658
[TBL] [Abstract][Full Text] [Related]
32. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
[TBL] [Abstract][Full Text] [Related]
33. Functional single-nucleotide polymorphisms in the DEFB1 gene are associated with systemic lupus erythematosus in Southern Brazilians.
Sandrin-Garcia P; Brandão LA; Guimarães RL; Pancoto JA; Donadi EA; Lima-Filho JL; Segat L; Crovella S
Lupus; 2012 May; 21(6):625-31. PubMed ID: 22323338
[TBL] [Abstract][Full Text] [Related]
34. The effects of MIR137HG genetic polymorphisms on the susceptibility of alcohol-induced osteonecrosis of the femoral head in a Chinese male population.
Guo Y; Cao Y; Feng X; Zhang D; Fan L; Shen C; He Y; Wang P; Wang P; Dong Y; Sheng G; Lv N
Gene; 2021 Dec; 804():145902. PubMed ID: 34403773
[TBL] [Abstract][Full Text] [Related]
35. High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.
Kuroda T; Tanabe N; Wakamatsu A; Takai C; Sato H; Nakatsue T; Wada Y; Nakano M; Narita I
Clin Rheumatol; 2015 Dec; 34(12):2071-7. PubMed ID: 26384821
[TBL] [Abstract][Full Text] [Related]
36. Gene testing for osteonecrosis of the femoral head in systemic lupus erythematosus using targeted next-generation sequencing: A pilot study.
Sun HS; Yang QR; Bai YY; Hu NW; Liu DX; Qin CY
World J Clin Cases; 2020 Jun; 8(12):2530-2541. PubMed ID: 32607330
[TBL] [Abstract][Full Text] [Related]
37. The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus.
Chen JM; Guo J; Wei CD; Wang CF; Luo HC; Wei YS; Lan Y
BMC Genet; 2015 Oct; 16():121. PubMed ID: 26474561
[TBL] [Abstract][Full Text] [Related]
38. Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.
Kim H; Cho C; Cho Y; Cho S; Yoon K; Kim K
BMC Musculoskelet Disord; 2011 Jul; 12():160. PubMed ID: 21752301
[TBL] [Abstract][Full Text] [Related]
39. CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
Wyles CC; Paradise CR; Houdek MT; Slager SL; Terzic A; Behfar A; van Wijnen AJ; Sierra RJ
Clin Orthop Relat Res; 2019 Aug; 477(8):1800-1812. PubMed ID: 31135556
[TBL] [Abstract][Full Text] [Related]
40. [A clinical study of femoral head osteonecrosis in patients with systemic lupus erythematosus.].
Wang DX; Li GY; Ma L; Wang GC
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):926-9. PubMed ID: 20079323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
